Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

The treatment improved hair growth and reduced scalp symptoms.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Blood metabolites significantly influence alopecia areata risk.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

A multidisciplinary approach is essential for effectively managing cutaneous lupus erythematosus.

Xinyang Tablet improves heart function in sepsis by reducing inflammation.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.